Lilly(LLY) Benzinga·2025-03-26 13:25Group 1 - Direxion has launched four single-stock leveraged and inverse ETFs focused on Eli Lilly & Co and Palo Alto Networks Inc, providing traders with tools to amplify their investments or hedge against market downturns in the pharmaceutical and cybersecurity sectors [1][2] - Eli Lilly is recognized for its leadership in healthcare innovation, while Palo Alto Networks is a leader in cybersecurity, making them suitable candidates for leveraged trading [2] - Recent performance shows Eli Lilly has increased by 9.99% over the past year but decreased by 6.85% in the last month, whereas Palo Alto Networks has risen by 32.51% year-over-year with a slight gain of 0.21% in the past month [3] Group 2 - The newly introduced ETFs are designed for short-term trading strategies and are not suitable for buy-and-hold investors due to their high volatility and risk [4] - These leveraged and inverse funds track individual stocks rather than indices, which contributes to their increased risk profile [4] - For high-risk tolerant traders, Direxion's ETFs present an opportunity to engage with fast-moving stocks using leverage [4]